- Home
- ZVRA vs NBB Comparison
ZVRA vs NBB Comparison
Compare ZVRA & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- NBB
- Stock Information
- Founded
- ZVRA 2006
- NBB 2009
- Country
- ZVRA United States
- NBB United States
- Employees
- ZVRA N/A
- NBB N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- ZVRA Health Care
- NBB Finance
- Exchange
- ZVRA Nasdaq
- NBB Nasdaq
- Market Cap
- ZVRA 467.6M
- NBB 470.6M
- IPO Year
- ZVRA 2015
- NBB N/A
- Fundamental
- Price
- ZVRA $8.99
- NBB $16.25
- Analyst Decision
- ZVRA Strong Buy
- NBB
- Analyst Count
- ZVRA 7
- NBB 0
- Target Price
- ZVRA $21.71
- NBB N/A
- AVG Volume (30 Days)
- ZVRA 1.5M
- NBB 73.9K
- Earning Date
- ZVRA 11-05-2025
- NBB 01-01-0001
- Dividend Yield
- ZVRA N/A
- NBB 8.64%
- EPS Growth
- ZVRA N/A
- NBB N/A
- EPS
- ZVRA 0.54
- NBB N/A
- Revenue
- ZVRA $84,388,000.00
- NBB N/A
- Revenue This Year
- ZVRA $336.43
- NBB N/A
- Revenue Next Year
- ZVRA $54.26
- NBB N/A
- P/E Ratio
- ZVRA $16.52
- NBB N/A
- Revenue Growth
- ZVRA 244.60
- NBB N/A
- 52 Week Low
- ZVRA $6.19
- NBB $13.67
- 52 Week High
- ZVRA $13.16
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- ZVRA 38.60
- NBB 45.46
- Support Level
- ZVRA $8.51
- NBB $16.25
- Resistance Level
- ZVRA $9.69
- NBB $16.50
- Average True Range (ATR)
- ZVRA 0.58
- NBB 0.17
- MACD
- ZVRA -0.15
- NBB -0.02
- Stochastic Oscillator
- ZVRA 15.26
- NBB 16.13
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.